Hesperidin Market

By Source;

Orange, Tangerine, and Others

By Grade;

Food Grade, Pharmaceutical Grade, and Cosmetic Grade

By Distribution Channel;

Online Stores, Supermarkets/Hypermarkets, Specialty Stores, and Others

By End Use;

Food and Beverage Industry, Dietary Supplement Industry, Pharmaceutical Industry, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn738879144 Published Date: August, 2025 Updated Date: September, 2025

Hesperidin Market Overview

Hesperidin Market (USD Million)

Hesperidin Market was valued at USD 115.52 million in the year 2024. The size of this market is expected to increase to USD 181.65 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.7%.


Hesperidin Market

*Market size in USD million

CAGR 6.7 %


Study Period2025 - 2031
Base Year2024
CAGR (%)6.7 %
Market Size (2024)USD 115.52 Million
Market Size (2031)USD 181.65 Million
Market ConcentrationMedium
Report Pages303
115.52
2024
181.65
2031

Major Players

  • Zhejiang Conler Pharmaceutical Co., Ltd.
  • Xi'an Hao-Xuan Bio-Tech Co., Ltd.
  • Chengdu Okay Plant & Chemical Co., Ltd.
  • Hunan NutraMax Inc.
  • Sichuan Xieli Pharmaceutical Co., Ltd.
  • Shaanxi Undersun Biomedtech Co., Ltd.
  • Chenguang Biotech Group Co., Ltd.
  • Chengdu Hawk Bio-Engineering Co., Ltd.
  • Hunan Jiudian Pharmaceutical Co., Ltd.
  • Chongqing Bull Animal Pharmaceutical Co., Ltd.

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Hesperidin Market

Fragmented - Highly competitive market without dominant players


The Hesperidin Market is evolving rapidly as industries recognize the value of natural bioflavonoids in wellness and healthcare. Adoption has risen by nearly 30%, driven by demand for plant-based antioxidants that deliver protective and therapeutic benefits. Its growing role in nutraceuticals, pharmaceuticals, and cosmetics highlights hesperidin’s expanding impact.

Health and Wellness Adoption
A surge in functional foods and supplements is fueling hesperidin consumption. Almost 40% of dietary formulations now feature bioflavonoids to support immune resilience and cardiovascular balance. With consumers prioritizing prevention over cure, hesperidin is emerging as a cornerstone of natural health products.

Pharmaceutical Relevance
Pharmaceutical applications represent nearly 35% usage, especially in products addressing circulatory wellness and inflammatory concerns. Its potent vascular-protective and antioxidant qualities make it a sought-after compound. Continuous clinical validation strengthens its credibility and accelerates adoption across modern therapeutic solutions.

Future Potential
The future of the Hesperidin Market is driven by innovation, with over 50% of manufacturers investing in advanced extraction and formulation technologies. As industries push for higher purity and efficiency, hesperidin is set to secure a vital role in wellness-driven consumer trends and therapeutic research.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Source
    2. Market Snapshot, By Grade
    3. Market Snapshot, By Distribution Channel
    4. Market Snapshot, By End Use
    5. Market Snapshot, By Region
  4. Hesperidin Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Health-conscious consumer trends.
        2. Demand for natural antioxidants.
        3. Increasing use in supplements.
      2. Restraints
        1. High extraction costs.
        2. Limited raw material access.
        3. Regulatory hurdles.
      3. Opportunities
        1. Pharma and nutraceutical growth.
        2. Asia-Pacific and Latin American markets.
        3. Advancements in extraction methods.
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Hesperidin Market, By Source, 2021 - 2031 (USD Million)
      1. Orange
      2. Tangerine
      3. Others
    2. Hesperidin Market, By Grade, 2021 - 2031 (USD Million)
      1. Food Grade
      2. Pharmaceutical Grade
      3. Cosmetic Grade
    3. Hesperidin Market, By Distribution Channel, 2021 - 2031 (USD Million)

      1. Online Stores

      2. Supermarkets/Hypermarkets

      3. Specialty Stores

      4. Others

    4. Hesperidin Market, By End Use, 2021 - 2031 (USD Million)
      1. Food and Beverage Industry
      2. Dietary Supplement Industry
      3. Pharmaceutical Industry
      4. Others
    5. Hesperidin Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Zhejiang Conler Pharmaceutical Co., Ltd.
      2. Xi'an Hao-Xuan Bio-Tech Co., Ltd.
      3. Chengdu Okay Plant & Chemical Co., Ltd.
      4. Hunan NutraMax Inc.
      5. Sichuan Xieli Pharmaceutical Co., Ltd.
      6. Shaanxi Undersun Biomedtech Co., Ltd.
      7. Chenguang Biotech Group Co., Ltd.
      8. Chengdu Hawk Bio-Engineering Co., Ltd.
      9. Hunan Jiudian Pharmaceutical Co., Ltd.
      10. Chongqing Bull Animal Pharmaceutical Co., Ltd.
  7. Analyst Views
  8. Future Outlook of the Market